C27. Hong YJ, Jeong MH, Shim DS, Lim SY, Yang BR, Lee SH, Lee SH, Park OY, Park WS, Kim JH, Choi MJ, Kim IS, Kim W, Ahn Y, Cho JG, Park JC, Kang JC; The clinical effects of the BiodivYsio Phosphorylcholine-coated Stent in patients with small coronary artery diseases. Korean Med J 2002;63(3)251-260.
(Abstract)
Background : The BiodivYsio stent is a balloon-expandable stent coated with phosphorylcholine designed to reduce the formation of thrombus and the risk of restenosis.
Methods : We prospectively studied 20 patients who underwent implantation of BiodivYsio stent (group I; 60.8±}9.3 years, male 60.0%) and compared to 20 patients who underwent balloon angioplasty alone (group II; 60.3±}7.9 years, male 45.0%) for small coronary arterial lesions (target arterial diameter was between 2.0 mm and 2.8 mm) between February 2001 and October 2001. Major adverse cardiac events such as acute myocardial infarction, target vessel revascularization and death were evaluated during hospital admission and at 6-months after percutaneous coronary intervention (PCI).
Results : During hospitalization, the incidence of acute myocardial infarction, target vessel revascularization and death was not different between the two groups. At follow-up coronary angiography 6 months after PCI, the incidence of restenosis was lower in group I than in group II (Group I; 3/20, 15.0% vs Group II; 9/20, 45.0%, p=0.032) and the incidence of target vessel revascularization (TLR) was lower in group I than in group II (Group I; 3/20, 15.0% vs Group II; 8/20, 40.0%, p=0.041).
Conclusion : Coronary BiodivYsio stenting in small coronary artery leads to excellent short- and mid-term clinical outcomes.
|
DATE : 16-03-14 13:09
HIT : 4,081
